Wang David H sold $8.8M of ACMR
Wang David H (See Remarks) sold 100,002 shares of ACM Research, Inc. (ACMR) at an average of $88.35 ($83.86–$93.04, $8.84M total) across 11 trades over 2026-06-03 to 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale reduces insider ownership and may influence short‑term price dynamics.
Market read
First‑report insider sell of $8.8M; modest but material for the stock, may trigger short‑term price pressure.
What to watch
No accompanying corporate news; the 10b5‑1 plan suggests pre‑planned execution, reducing informational asymmetry.
Background
Form 4 filings disclose insider transactions and are primary sources for new insider activity.
Ticker impact
Officer/director sold $8.8M of shares via a 10b5‑1 plan, reducing his stake to 802,708 shares.
potential downward pressure as the market prices in the insider sale
The sale size ($8.8M) is material for a mid‑cap biotech and was disclosed for the first time via a Form 4.
Market effects
May prompt scrutiny of insider activity in the biotech sector.
Limited to U.S. markets where ACMR trades.
Low; impact confined to the issuer and its investors.
Counterpoint
The sale could be a routine liquidity move, not a bearish signal.
Key entities
- Officer/DirectorWang David H
10% owner of ACM Research who executed the sale.
- CompanyACM Research, Inc.
Biotech equipment maker listed on NASDAQ under ACMR.
